The motion led by California’s attorney general contends Corteva’s split would help the company avoid liabilities in a federal PFAS case.
Read More
The agreement includes an initial $8 million obligation to launch VEDDER with provisions for a potential follow-on production award of up to $500 million.
Read MorePrediction market websites Kalshi and Polymarket this year began letting people wager on U.S. Food and Drug Administration decisions.
Retatrutide, an experimental injectable medication that has helped clinical trial participants lose more weight than any previous obesity medication, has a booming black market.
Pharmaceutical Product Development, a subsidiary of Thermo Fisher Scientific Inc., is planning to hire 100 to 150 employees at the facility.
Eli Lilly this year has been on an acquisition spree, fueled by the successes of its blockbuster GLP-1 medications.
The 11-bed Pediatric Medical-Behavioral Health Unit is expected to serve 325 patients annually after it opens in mid-to-late September.
The center’s goal is to expand access to personalized treatment for patients with cancer and further position the state as a leader in the practice known as theranostics.
The acquisition gives Indianapolis-based BiomEdit access to Folium Sciences’ poultry feed additive BiomElix One and its Guided Biotics CRISPR-Cas technology.
The blood test is designed to help physicians identify amyloid pathology, a key feature of Alzheimer’s disease, in people ages 55 years and older.
Indiana’s health care and life sciences industries are growing, but they continue to face a shortage of employees for some of their most crucial roles.
Lilly and Boston-based Amplitude Therapeutics plan to develop vaccine candidates using Amplitude’s trans-amplifying RNA, or taRNA, technology.
The five-year program announced will provide training for rural emergency department and pre-hospital staff in obstetric and pediatric emergency standards.
Residents of at least two facilities adjacent to the White River were moved to temporary housing over the weekend.
The program, which will launch next year, will be the third in the state to offer a bachelor of science degree in respiratory therapy, one of health care’s fastest-growing fields.
Rod Taylor was most recently senior director of cardiometabolic thought leader strategy at Indianapolis-based Eli Lilly and Co.
The drugmaker says it plans to sue U.S. businesses that sell retatrutide products illegally. It’s also asking regulators to do more to rein in the illicit market.
The Life Sciences ITA is one of several apprenticeship-focused groups kickstarted thanks to grant funding from the Richard M. Fairbanks Foundation.
Over the past 14 years, Rehab Industries has grown from 200 employees to 850. McGinley expects to reach 1,000 employees by next year.
Dr. Alastair Thompson has more than 40 years of experience in breast cancer research and patient care.
The Indianapolis-based drugmaker reported profit of $7.1 billion for the second quarter, up from $5.7 billion in the same period a year earlier.
The current contract between Ascension St. Vincent and UHC expires Saturday, but network access is extended through Aug. 7 while a new deal is finalized.
